Loading…

Assoc. Prof. Pakatip Ruenraroengsak

Department of Pharmacy


  pakatip.rue@mahidol.ac.th

Education Background

  • B.Sc. (Pharmacy), Mahidol University, Thailand 
  • M.Sc. (Pharmaceutical science), Mahidol University, Thailand 
  • Ph.D. (Nanotechnology for drug delivery), The School of Pharmacy, University of London

Work Experience

  • 2017-Current: Lectureship position, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand, 10400 
  • 2016-2017: Senior Postdoctoral Research Associate and Lab manager, Department of Materials and London, Centre for Nanotechnology, SW7 2AZ, UK. Funding body: The European Resuscitation Council (ERC) and Welcome Trust Facility Network of Excellence, UK. 
  • 2015-2016: Senior Postdoctoral Research Associate, Department of Materials, and department of Cancer and Surgery, Imperial College London, SW7 2AZ, UK. Funding body: Biomedical Research Centre (BRC), UK. 
  • 2011-2015: Postdoctoral Research Associate (PDRA) and lab manager, Department of Materials and London Centre for Nanotechnology, Imperial College London SW7 2AZ, UK. Funding body: European Resuscitation Council (ERC) and Biomedical Research Centre (BRC), Biotechnology and Biological Sciences Research Council (BBSRC) and Welcome Trust Facility Network of Excellence, UK. 
  • 2008-2011: PDRA National Heart and Lung Institute (NHLI), Imperial College London, Dovehouse st, London, SW3 6LY, UK. Funding body: Biotechnology and Biological Sciences Research Council (BBSRC) and Medical Research Council (MRC), UK.

Expertise

  • Nanomedicines, Nanotheranostics, Non-viral vector for biotherapeutics, Drug targeting, nanobio-materials, tissue engineering and regenerative medicine

Award & Honor

  • Best poster presentation award “Silver medal” (PST 2019) poster prizes, Swansea, 2019 
  • British Association for Lung Research (BALR) poster prizes, Swansea, 2011 (£250)
  • British Association for Lung Research (BALR) poster prizes, 2010 (£250)
  • British Association for Lung Research (BALR) poster prizes, 2009 (£250) 
  • European Respiratory Society (ERS) travel award from European Respiratory Society to Estoril, Portugal, 2009 (€500) 
  • British Lung Foundation/Allen&Hanburys (BALF) travel award to present my work at American Thoracic Society (ATS), San Diego, USA, 2009 (£700)

Current Research


Publication

Year 2026

1.

Panduratin A from Boesenbergia rotunda suppresses hepatitis B virus by targeting HNF1α and synergizing with antiviral agents

Thongsri P, Pewkliang Y, Borwornpinyo S, Wongkajornsilp A, Ruenraroengsak P, Anurathapan U, Sobhonslidsuk A, Hongeng S, Sa-Ngiamsuntorn K.
Chin Med 2026 Jan 3 , 2026.

2.

Surface modification of gallium nanomaterials with a metal-phenolic network for biomedical applications

Govindaraj D; Chimphlee W; Wongprasert I; Sae-be A; Namporn T; Lertsathitphong P; Ruenraroengsak P; Nasongkla N; O'Mullane AP; Lertanantawong B.
Inorganic Chemistry Communications 2026; 185(116044):- , 2026.

Year 2025

3.

Evidence of Mpox clade IIb infection in primary human alveolar epithelium

Namporn T, Manopwisedjaroen S, Ngodngamthaweesuk M, Pasomsub E, Jiravejchakul N, Saengfak R, Nealiga MJ, Sea-Be A, Basu A, Naruphontjirakul P, Hongeng S, Tetley TD, Thitithanyanont A, Ruenraroengsak P.
Emerging Microbes & Infections 2025 Dec;14(1):2477845 , 2025.

Year 2024

4.

Delivery of Avocado Seed Extract Using Novel Charge-Switchable Mesoporous Silica Nanoparticles with Galactose Surface Modified to Target Sorafenib-Resistant Hepatocellular Carcinoma

Basu A; Sae-Be A, Namporn T, Suriyaphan O, Sithisarn P, Leanpolchareanchai J, Plommaithong P, Chatsukit A, Sa-Ngiamsuntorn K, Naruphontjirakul P, Ruenraroengsak P.
International journal of nanomedicine 2024 Oct 14;19:10341-10365 , 2024.

5.

Development of roselle ointment with antibacterial effects

Chongwilaikasem N, Sithisarn P, Rojsanga P, Ruenraroengsak P, Sithisarn P.
Pharmaceutical Sciences Asia 2024; 51():369-380 , 2024.

6.

Inhibitory effects against zoonotic bacteria by Oroxylum indicum ointment and effects to dog wound

Sithisarn P; Rojsanga P; Ruenraroengsak P; Sithisarn P.
Journal of Advanced Pharmaceutical Technology and Research 2024; 15():156-160 , 2024.

Year 2023

7.

Comparative Study between the 3D-Liver Spheroid Models Developed from HepG2 and Immortalized Hepatocyte-Like Cells with Primary Hepatic Stellate Coculture for Drug Metabolism Analysis and Anticancer Drug Screening

Sae-be A, Wiwatpanit T, Varatthan T, Namporn T, Laungkulldej S, Thiabma R, Jaiboonma A, Sa-ngiamsuntorn K, Elson D, Porter AE, Sathirakul K, Hongeng S, Ruenraroengsak P.
Advanced Therapeutics 2023; 6(2200169):- , 2023.

8.

Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma

Basu A; Namporn T; Ruenraroengsak P.
Pharmaceutics 2023 Apr;12(2):1339-1357 , 2023.

9.

Multifunctional Zn and Ag co-doped bioactive glass nanoparticles for bone therapeutic and regeneration

Naruphontjirakul P, Kanchanadumkerng P, Ruenraroengsak P.
Scientific Reports , 2023.

Year 2020

10.

Effect of silver nanospheres and nanowires on human airway smooth muscle cells: Role of sulfidation

Michaeloudes C, Seiffert J, Chen S, Ruenraroengsak P, Bey L, Theodorou IG, Ryan M, Cui X, Zhang J, Shaffer M, Tetley T, Porter AE, Chung KF*..
Nanoscale advances 2020; 2(12): 5635-5647., 2020.

11.

Immortalisation of primary human alveolar epithelial lung cells using a non-viral vector to study respiratory bioreactivity in vitro

Katsumiti A*, Ruenraroengsak P, Cajaraville MP, Thorley AJ, Tetley TD..
Scientific reports 2020; 10(1): 20486., 2020.

Year 2019

12.

Frizzled-7-targeted delivery of zinc oxide nanoparticles to drug-resistant breast cancer cells.

Ruenraroengsak P*, Kiryushko D, Theodorou IG, Klosowski MM, Taylor ER, Niriella T, Palmieri C, Yagüe E, Ryan MP, Coombes RC, Xie F, Porter AE..
Nanoscale 2019; 11(7); 12858-12870., 2019.

13.

Towards multiplexed near-infrared cellular imaging using gold nanostar arrays with tunable fluorescence enhancement

Theodorou IG, Ruenraroengsak P, Gonzalez-Carter DA, Jiang Q, Yagüe E, Aboagye EO, Coombes RC, Porter AE, Ryan MP, Xie F*..
Nanoscale 2019; 11(4): 2079-2088, 2019.

Year 2007

14.

In vitro investigation of the protective effects of tannic acid against the activities of Naja kaouthia venom

Pithayanukul P*, Ruenraroengsak P, Bavovada R, Pakmanee N, Suttisri R..
Pharm Biol 2007; 45(2) Feb: 94-97, 2007.

Year 2005

15.

Inhibition of Naja kaouthia venom activities by plant polyphenols.

Pithayanukul P*, Ruenraroengsak P, Bavovada R, Pakmanee N, Suttisri R, Saenoon S..
Journal of Ethnopharmacology 2005.97, 527-533., 2005.


Presentation

Year 2004

1.

สมุนไพรต้านพิษงู

พิมลพรรณ พิทยานุกุล ผกาทิพย์ รื่นระเริงศักดิ์ รพีพล ภโววาท นฤมล พักตร์มณี รุทธ์ สุทธิศรี.
การประชุมเรื่องงูพิษและพิษงูในประเทศไทย จัดโดยสถานเสาวภา สภากาชาดไทย 2004, 2004.

เกี่ยวกับภาควิชา

The ultimate success of a pharmacist's practice relies on applying expertise to minimize the consumer's risk of harm from medication while maximizing the positive outcomes in disease prevention and treatment.

The ultimate success of a pharmacist's practice relies on applying expertise to minimize the consumer's risk of harm from medication while maximizing the positive outcomes in disease prevention and treatment.
Pradit Hutangura
The First Dean of Faculty of Pharmacy, Mahidol University
Copyright © 2021 - 2026
Division of Information Technology and Instructional Media, Faculty of Pharmacy, Mahidol University.
Cookie Notice
This site uses cookies from us and our partners to make your browsing experience more efficient, relevant, convenient and personal. In some cases, they are essential to making the site work properly. By accessing this site, you direct us to use and consent to the use of cookies. You can change your settings by clicking on the Cookie Settings link.